	US 11,896,033 B2
	Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
Mikkel Klausen, Copenhagen (DK); Kirk Matthew Schnorr, Holte (DK); Soeren Nymand-Grarup, Copenhagen (DK); Peter Bjarke Olsen, Copenhagen (DK); Marianne Thorup Cohn, Copenhagen (DK); Robert Piotr Olinski, Vaerloese (DK); Marc Dominique Morant, Frederiksberg (DK); Ming Li, Beijing (CN); Ye Liu, Beijing (CN); Lars Kobbeeroee Skov, Ballerup (DK); Dominique Aubert Skovlund, Vaerloese (DK); and Han Bucong, Beijing (CN)
Assigned to Novozymes A/S, Bagsvaerd (DK)
Appl. No. 16/462,764
Filed by Novozymes A/S, Bagsvaerd (DK)
PCT Filed Dec. 21, 2017, PCT No. PCT/CN2017/117765 § 371(c)(1), (2) Date May 21, 2019, PCT Pub. No. WO2018/113745, PCT Pub. Date Jun. 28, 2018.
Claims priority of application No. PCT/CN2016/111317 (WO), filed on Dec. 21, 2016; and application No. PCT/CN2017/075978 (WO), filed on Mar. 8, 2017.
Prior Publication US 2021/0274810 A1, Sep. 9, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A23K 20/147 (2016.01); A23K 50/30 (2016.01); A23K 50/75 (2016.01); A23K 10/30 (2016.01); C12N 9/36 (2006.01); C12N 15/81 (2006.01)

CPC A23K 20/147 (2016.05) [A23K 10/30 (2016.05); A23K 50/30 (2016.05); A23K 50/75 (2016.05); C12N 9/2462 (2013.01); C12N 15/815 (2013.01); C12Y 302/01017 (2013.01)]

20 Claims

1. A recombinant host cell comprising a polynucleotide encoding a GH25 polypeptide having lysozyme activity, wherein the polypeptide has at least 80% sequence identity to SEQ ID NO: 9 and the polynucleotide is operably linked to one or more control sequences that direct the production of the polypeptide.